Oxilofrine

Last updated

Oxilofrine
Oxilofrin Structural Formulae V.1.svg
Clinical data
Trade names Carnigen, Cophylac, Suprifen, others
Other namesOxilophrine; Hydroxyephedrine; (±)-Hydroxyephedrine; 4-Hydroxyephedrine; p-Hydroxyephedrine; Oxyephedrine; Methylsynephrine; 4-HMP; 4,β-Dihydroxy-N-methyl-α-methylphenethylamine; 4,β-Dihydroxy-N-methylamphetamine
Routes of
administration 		Oral [1]
ATC code
  • None
Legal status
Legal status
Identifiers
  • (1S*,2R*)-(±)-4-(1-Hydroxy-2-methylamino-propyl)phenol
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.006.067 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C10H15NO2
Molar mass 181.235 g·mol−1
  • InChI=1S/C10H15NO2/c1-7(11-2)10(13)8-3-5-9(12)6-4-8/h3-7,10-13H,1-2H3 Yes check.svgY
  • Key:OXFGTKPPFSCSMA-UHFFFAOYSA-N Yes check.svgY
   (verify)

Oxilofrine, sold under the brand names Carnigen and Suprifen among others, is a sympathomimetic medication which has been used as an antihypotensive agent and cough suppressant. [4] [5] [6] It is taken by mouth. [1]

Contents

Oxilofrine acts as a norepinephrine releasing agent and hence is an indirectly acting sympathomimetic. [7] [6] [8] It is a substituted amphetamine and is closely related to ephedrine (with oxilofrine also being known as 4-hydroxyephedrine). [4] [8]

Oxilofrine was first developed in the 1930s. [9] It is mostly no longer marketed today. [10]

Pharmacology

Oxilofrine is described as an ephedrine-like indirectly acting sympathomimetic and antihypotensive agent. [4] [7] [6] It acts as a norepinephrine releasing agent and indirectly activates the α- and β-adrenergic receptors. [6] [8] The drug has positive inotropic effects (increases myocardial contractility). [6]

Chemistry

Oxilofrine, also known as 4,β-dihydroxy-N-methyl-α-methylphenethylamine or as 4,β-dihydroxy-N-methylamphetamine, is a substituted phenethylamine and amphetamine derivative. [4] [10] It is the racemic 4-hydroxylated analogue of ephedrine ((1R,2S)-β-hydroxy-N-methylamphetamine). [4] It is also related to pholedrine (4-hydroxy-N-methylamphetamine). [4]

The predicted log P of oxilofrine ranges from -0.13 to 0.6. [11] [1] [12] It is more hydrophilic than ephedrine, which has an experimental log P of 1.13 and a predicted log P of 0.9 to 1.32. [13] [14] [15]

History

Oxilofrine was originally developed in the 1930s as a cardiac stimulant. Trade names included Suprifen (Bayer) and, combined with an adenosine-containing standardized organ extract, Carnigen (Hoechst AG). [9]

In combination with normethadone, it was marketed as a cough suppressant under the trade name Ticarda. As of 2021, this formulation was still manufactured in Canada by Valeant and sold as Cophylac. [16]

Several other sympathomimetics and vasodilators were developed as chemical derivatives of oxilofrine, such as the β2-adrenergic receptor agonists buphenine and isoxsuprine. [17] [18]

Society and culture

Names

Oxilofrine is the generic name of the drug and its INN Tooltip International Nonproprietary Name. [4] [7] [10] It is also known by synonyms including methylsynephrine, oxyphedrine, and hydroxyephedrine. [4] [10] Brand names of oxilofrine include Carnigen, Cophylac (with normethadone), Suprifen, and Ticarda (also with normethadone), among others. [4] [10] [9]

Availability

Oxilofrine has been marketed in Austria, Canada, and Germany. [4] [10]

Use in exercise and sports

Oxilofrine is currently a World Anti-Doping Agency (WADA) prohibited substance when used in competition. [19] It has been found as an adulterant in some dietary supplements. [9] [20] Even after receiving warning letters from the FDA, [21] some sports and weight loss supplement companies continue to use oxilofrine as an undeclared ingredient in their products despite it being prohibited. [22]

List of doping cases

Several doping cases involving oxilofrine have been publicized, including:

  • In 2009, Brazilian/American cyclist Flávia Oliveira was suspended for 2 years after taking a supplement known as "HyperDrive 3.0+" which contained methylsynephrine, a chemical equivalent of oxilofrine, among other substances. [23] Her sentence was eventually reduced to 18 months after an appeal as there was enough evidence that she had unknowingly consumed said substance as the old label did not list methylsynephrine. [24]
  • On 18 September 2010, Vietnamese weightlifter Hoàng Anh Tuấn, silver medalist in 2008 Summer Olympics was handed a four year ban, later reduced to two years, for testing positive with the substance. It was found out that the substance came from unlabeled drinks he consumed during his training in China. [25]
  • On July 14, 2013, Jamaican runners Asafa Powell and Sherone Simpson tested positive for oxilofrine prior to the 2013 World Athletics Championships. [26] Powell, however, maintained that he did not take any banned supplements knowingly or willfully. [27] Powell voluntarily withdrew as a result of the test. On 10 April 2014, both athletes received an 18-month suspension from competing, which was set to expire in December that year. [28] However, after appealing to the Court of Arbitration for Sport (CAS), both athletes' suspensions were lifted on 14 July 2014. [29]
  • On July 16, 2015, Red Sox pitching prospect Michael Kopech was suspended without pay for 50 games after testing positive for oxilofrine, which is a banned substance under the Minor League Drug Prevention and Treatment Program. Kopech denied knowingly taking the substance. [30]
  • In October 2018, the WBO stripped boxer Billy Joe Saunders of its middleweight world title after he tested positive for oxilofrine, as a result of a drug test administered by the Voluntary Anti-Doping Association (VADA). In his defense, Saunders held that while the substance was proscribed by VADA it was not banned "out of competition" by UK Anti-Doping, or the British Boxing Board of Control, but this appeal was rejected. [31]

Other drugs

Oxilofrine is a known metabolite of para-methoxymethamphetamine (PMMA). [6]

Related Research Articles

<span class="mw-page-title-main">Pseudoephedrine</span> Pharmaceutical drug

Pseudoephedrine, sold under the brand name Sudafed among others, is a sympathomimetic medication which is used as a decongestant to treat nasal congestion. It has also been used off-label for certain other indications, like treatment of low blood pressure. At higher doses, it may produce various additional effects including stimulant, appetite suppressant, and performance-enhancing effects. In relation to this, non-medical use of pseudoephedrine has been encountered. The medication is taken by mouth.

<span class="mw-page-title-main">Ephedrine</span> Medication and stimulant

Ephedrine is a central nervous system (CNS) stimulant and sympathomimetic agent that is often used to prevent low blood pressure during anesthesia. It has also been used for asthma, narcolepsy, and obesity but is not the preferred treatment. It is of unclear benefit in nasal congestion. It can be taken by mouth or by injection into a muscle, vein, or just under the skin. Onset with intravenous use is fast, while injection into a muscle can take 20 minutes, and by mouth can take an hour for effect. When given by injection, it lasts about an hour, and when taken by mouth, it can last up to four hours.

<span class="mw-page-title-main">Ephedra (medicine)</span> Medicinal preparation from the plant Ephedra sinica

Ephedra is a medicinal preparation from the plant Ephedra sinica. Several additional species belonging to the genus Ephedra have traditionally been used for a variety of medicinal purposes, and are a possible candidate for the soma plant of Indo-Iranian religion. It has been used in traditional Chinese medicine, in which it is referred to as Ma Huang, for more than 2,000 years. Native Americans and Mormon pioneers drank a tea brewed from other Ephedra species, called "Mormon tea" and "Indian tea".

<span class="mw-page-title-main">Phenylpropanolamine</span> Sympathomimetic agent

Phenylpropanolamine (PPA), sold under many brand names, is a sympathomimetic agent which is used as a decongestant and appetite suppressant. It was previously commonly used in prescription and over-the-counter cough and cold preparations. The medication is taken by mouth.

In competitive sports, doping is the use of banned athletic performance-enhancing drugs (PEDs) by athletes, as a way of cheating. As stated in the World Anti-Doping Code by WADA, doping is defined as the occurrence of one or more of the anti-doping rule violations outlined in Article 2.1 through Article 2.11 of the Code. The term doping is widely used by organizations that regulate sporting competitions. The use of drugs to enhance performance is considered unethical and is prohibited by most international sports organizations, including the International Olympic Committee. Furthermore, athletes taking explicit measures to evade detection exacerbate the ethical violation with overt deception and cheating.

Sherone Simpson is a Jamaican retired track and field sprint athlete. She is a gold medalist in the 4 × 100 m relay from the 2004 Olympics and silver medalist in 2005 World Championships and now is the silver medalist in the individual event at the 2008 Summer Olympics, after she tied for second with Kerron Stewart in a photo finish.

<span class="mw-page-title-main">Metaraminol</span> Antihypotensive medication

Metaraminol, also known as metaradrine and sold under the brand names Aramine and Pressonex among others, is a sympathomimetic medication which is used in the prevention and treatment of hypotension, particularly as a complication of anesthesia. It is given by intramuscular or intravenous administration.

Performance-enhancing substances (PESs), also known as performance-enhancing drugs (PEDs), are substances that are used to improve any form of activity performance in humans.

β-Methylphenethylamine Chemical compound

β-Methylphenethylamine is an organic compound of the phenethylamine class, and a positional isomer of the drug amphetamine, with which it shares some properties. In particular, both amphetamine and β-methylphenethylamine are human TAAR1 agonists. In appearance, it is a colorless or yellowish liquid.

<span class="mw-page-title-main">Mephentermine</span> Adrenergic and dopaminergic cardiac stimulant

Mephentermine, sold under the brand name Wyamine among others, is a sympathomimetic medication which was previously used in the treatment of low blood pressure but is mostly no longer marketed. It is used by injection into a vein or muscle, by inhalation, and by mouth.

<span class="mw-page-title-main">Norfenefrine</span> Sympathomimetic drug

Norfenefrine, also known as meta-octopamine or norphenylephrine and sold under the brand name Novadral among others, is a sympathomimetic medication which is used in the treatment of hypotension. Along with its structural isomer p-octopamine and the tyramines, norfenefrine is a naturally occurring endogenous trace amine and plays a role as a minor neurotransmitter in the brain.

<span class="mw-page-title-main">Methylhexanamine</span> Chemical compound

Methylhexanamine is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the 1980s.

<span class="mw-page-title-main">Phenpromethamine</span> Sympathomimetic nasal decongestant (Phenethylamine group)

Phenpromethamine, also known as N,β-dimethylphenethylamine, is a sympathomimetic nasal decongestant of the phenethylamine group. It was previously marketed as a nasal inhaler from 1943 through 1960 but is no longer available. The medication is a stimulant and is banned by the World Anti-Doping Agency. It has been detected in dietary supplements starting in the 2010s.

<span class="mw-page-title-main">Pholedrine</span> Chemical compound

Pholedrine, also known as 4-hydroxy-N-methylamphetamine and sold under the brand names Paredrinol, Pulsotyl, and Veritol among others, is a sympathomimetic drug used in topical eye drops to dilate the pupil. It can be used to diagnose Horner's syndrome.

<span class="mw-page-title-main">Methylephedrine</span> Chemical compound

Methylephedrine, sold under the brand name Metheph among others, is a sympathomimetic medication described as an antiasthmatic agent and used to treat coughing and nasal congestion. It is reported to be used in various over-the-counter cough and cold preparations throughout the world, including Japan.

Doping, or the use of restricted performance-enhancing drugs in the United States occurs in different sports, most notably in the sports of baseball and football.

Doping in figure skating involves the use of illegal performance-enhancing drugs (PEDs), specifically those listed and monitored by the World Anti-Doping Agency (WADA). Figure skaters occasionally have positive doping results but it is not common. Bans can be enforced on figure skaters by the International Skating Union (ISU) and each country's individual skating federation. These bans can often be career ending due to the competitive nature of figure skating. A ban may be revoked if it can be proved that the skater tested positive for a prescribed medication. Some figure skaters will use PEDs to help with recovery time, allowing them to train harder and longer. Figure skating is an aesthetic sport that combines both athleticism and artistic licence, where weight-loss substances will have little effect on athletic performance but skaters may be perceived as more graceful and sleek, which is required for an athlete to be competitive.

<span class="mw-page-title-main">Deterenol</span> Chemical compound

Deterenol is a stimulant drug which acts as a beta agonist. It has been found as an ingredient of dietary supplement products, but is banned in most countries due to risk of cardiac arrest.

<span class="mw-page-title-main">Substituted β-hydroxyamphetamine</span> Class of compounds based upon the β-hydroxyamphetamine structure

Substituted β-hydroxyamphetamines, or simply β-hydroxyamphetamines, also known as substituted phenylisopropanolamines, substituted phenylpropanolamines, substituted norephedrines, or substituted cathinols, are derivatives of β-hydroxyamphetamine with one or more chemical substituents. They are substituted phenethylamines, phenylethanolamines (β-hydroxyphenethylamines), and amphetamines (α-methylphenethylamines), and are closely related to but distinct from the substituted cathinones (β-ketoamphetamines). Examples of β-hydroxyamphetamines include the β-hydroxyamphetamine stereoisomers phenylpropanolamine and cathine and the stereospecific N-methylated β-hydroxyamphetamine derivatives ephedrine and pseudoephedrine, among many others.

References

  1. 1 2 3 "Oxilofrine: Uses, Interactions, Mechanism of Action". DrugBank Online. 31 December 1957. Retrieved 1 September 2024.
  2. ↑ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  3. ↑ "Methylsynephrine in Dietary Supplements". FDA . February 22, 2023. Retrieved June 9, 2023.
  4. 1 2 3 4 5 6 7 8 9 10 Schweizerischer Apotheker-Verein (2000). Index Nominum 2000: International Drug Directory. Medpharm Scientific Publishers. p. 772. ISBN   978-3-88763-075-1 . Retrieved 2024-09-01.
  5. ↑ Fourcroy JL (2008). Pharmacology, doping and sports: a scientific guide for athletes, coaches, physicians, scientists and administrators. Taylor & Francis. ISBN   978-0-415-42845-3.
  6. 1 2 3 4 5 6 Docherty JR (June 2008). "Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)". Br J Pharmacol. 154 (3): 606–622. doi:10.1038/bjp.2008.124. PMC   2439527 . PMID   18500382.
  7. 1 2 3 Morton IK, Hall JM (2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Netherlands. p. 211. ISBN   978-94-011-4439-1 . Retrieved 2024-09-01.
  8. 1 2 3 Derendorf H (1995). Drug Actions: Basic Principles and Theraputic Aspects. CRC-Press. p. 227. ISBN   978-0-8493-7774-7 . Retrieved 1 September 2024.
  9. 1 2 3 4 Cohen PA, Avula B, Venhuis B, Travis JC, Wang YH, Khan IA (January 2017). "Pharmaceutical doses of the banned stimulant oxilofrine found in dietary supplements sold in the USA". Drug Testing and Analysis. 9 (1): 135–142. doi: 10.1002/dta.1976 . PMID   27062112.
  10. 1 2 3 4 5 6 "Oxilofrine". drugs.com. 2013-07-17. Archived from the original on 2016-04-13. Retrieved 2024-09-01.
  11. ↑ "Suprifen". PubChem. Retrieved 1 September 2024.
  12. ↑ "oxilofrine". ChemSpider. 1 September 2024. Retrieved 1 September 2024.
  13. ↑ "Ephedrine". PubChem. Retrieved 30 August 2024.
  14. ↑ "Ephedrine: Uses, Interactions, Mechanism of Action". DrugBank Online. 29 April 2016. Retrieved 14 July 2024.
  15. ↑ "L-(−)-Ephedrine". ChemSpider. 30 August 2024. Retrieved 30 August 2024.
  16. ↑ "Prescribing Information Including Patient Medication Information – Cophylac® Drops" (PDF). Valeant Canada. 2010-01-17. Retrieved 2022-01-06.
  17. ↑ Külz F, Schneider M (1950). "Über neue gefäßerweiternde Sympathomimetika" [On new vasodilating sympathomimetics]. Klin Wochenschr (in German). 28 (31–32): 535–537. doi:10.1007/BF01481535. PMID   14775050.
  18. ↑ Freedman L (1955). "Arlidin: a new vasodilative sympathomimetic drug". Angiology. 6 (1): 52–58. doi:10.1177/000331975500600106. PMID   14350296. S2CID   46317963.
  19. ↑ "Substances Prohibited In-Competition". WADA. Archived from the original on 2013-07-02. Retrieved 2013-07-15.
  20. ↑ Zovko Končić M (April 2018). "Getting More Than You Paid For: Unauthorized "Natural" Substances in Herbal Food Supplements on EU Market". Planta Medica. 84 (6–07): 394–406. doi: 10.1055/s-0044-100042 . PMID   29341031.
  21. ↑ "Products & Ingredients - Methylsynephrine in Dietary Supplements". Center for Food Safety and Applied Nutrition. U.S. Food and Drug Administration. 22 October 2020.
  22. ↑ Cohen PA, Wen A, Gerona R (December 2018). "Prohibited Stimulants in Dietary Supplements After Enforcement Action by the US Food and Drug Administration". JAMA Internal Medicine. 178 (12): 1721–1723. doi:10.1001/jamainternmed.2018.4846. PMC   6583602 . PMID   30422217.
  23. ↑ Pelkey C (2010-04-13). "Oliveira suspended for two years". Velonews. Archived from the original on 2015-10-06.
  24. ↑ Pelkey C (2011-02-24). "Court of Arbitration for Sport reduces Flavia Oliveira suspension". Velonews. Archived from the original on 2015-12-23.
  25. ↑ "Dính doping, lực sỹ Hoàng Anh Tuấn bị cấm thi đấu 2 năm". dantri.com.vn. 22 January 2011.
  26. ↑ "Jamaicans Powell, Simpson test positive - SuperSport - Athletics". SuperSport. Reuters. Retrieved 2013-07-15.
  27. ↑ "Jamaican Sprinter Asafa Powell slapped 18-month ban for doping". IANS. news.biharprabha.com. Archived from the original on 14 April 2014. Retrieved 10 April 2014.
  28. ↑ "Asafa Powell banned for 18 months for doping". BBC Sport. 10 April 2014. Archived from the original on 9 May 2014.
  29. ↑ "Jamaican sprinters Asafa Powell and Sherone Simpson have doping bans cut". The Guardian . 14 July 2014. Retrieved 14 July 2014.
  30. ↑ Wild D (16 July 2015). "Red Sox No. 10 prospect Kopech suspended". MiLB.com. Archived from the original on 9 March 2016. Retrieved 8 March 2016.
  31. ↑ Worsell E (12 October 2018). "The ins and outs of Billy Joe Saunders, oxilofrine and VADA". Boxing News.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.